Latest Strategy Changes News

Boresight Ltd has secured a lease for a new 812 square metre manufacturing hub in Huntsville, Alabama, vastly expanding its US production capacity for aerial target drones amid rising military demand.

Barramundi’s portfolio returned a solid 3.8% gross gain in Q2 2026, driven by strong AI-related infrastructure plays and takeover interest in key holdings, despite sector volatility and profit downgrades in healthcare and logistics.

Kingfish Limited outperformed the S&P/NZX50G with an 8.7% gross portfolio return in Q2 2026, driven by strong results from Fisher & Paykel Healthcare, Vista Group, and Infratil, while a2 Milk faced supply chain and regulatory challenges.

Fletcher Building and the New Zealand Government have struck a $60 million deal to keep Golden Bay Cement's Northland plant operational until at least 2040, safeguarding a critical domestic supply chain and addressing carbon cost challenges.

TradeWindow Holdings reported a 20% increase in trading revenue to $9.6 million and improved its EBITDA loss to $1.2 million, while advancing its AI-driven FreightAI platform on track for a 2027 commercial release.

European Resources Limited has boosted its Korsnäs rare earth project with a 15.4 million tonne Inferred Mineral Resource and promising metallurgical advances, while new seismic anomalies open fresh exploration avenues.

International Equities Corporation Ltd (ASX:IEQ) posted a modest profit for the June 2026 quarter, reversing prior losses amid a challenging economic backdrop that forced the company to exit its hotel and tourism activities.

Iltani Resources has demonstrated significant grade upgrades and waste rejection in first-pass TOMRA ore sorting tests at its Orient Silver-Indium Project, advancing plans for bulk testing and potential cost savings.

Coventry Group’s Q4 FY26 results show a strong operational turnaround with sales up 11.7% quarter-on-quarter and EBITDA almost doubling to $4.1 million, backed by a $10 million cost reduction program and positive cash flow.

Starpharma Holdings is raising approximately $32 million through a fully underwritten 1-for-7.5 renounceable entitlement offer priced at $0.57 per share, discounting the stock by 25%. Proceeds will fund the DEP HER2-Lu Phase 1 trial and expand its dendrimer-based oncology pipeline.

Excelsior Capital Limited plans a capital return of approximately A$27.43 million, about 94.6 cents per share, as it moves to wind up its investment portfolio and delist from the ASX. Shareholder approval is sought at a meeting on 17 August 2026, with trading suspension and removal from the official list scheduled for late August.

Tartana Minerals has locked in a $5.18 million placement with Chinese mining giant Xingye Gold at a striking 165% premium to its last traded price, setting the stage for accelerated exploration and a new strategic partnership.